Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Hair loss in women linked to higher sexual dysfunction risk.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Menopause affects hair and skin; more research needed for treatment.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Neurosteroids show promise for treating epilepsy and more research is needed.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Eating certain seeds may help reduce symptoms of Polycystic Ovary Syndrome.

Ovarian Hyperthecosis caused hypersexuality in an older woman and was successfully treated with surgery.

The 2024 guideline updates recommendations for genetic testing, imaging, and sperm retrieval in male infertility.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.